Global Urology Guidewire Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation & Forecast 2024

Industry : Healthcare Date : February 28th, 2019
Tutorials Get 15% Discount on First Report

The global urology guidewire market being a steady progressive market, generated revenue of USD 333.82 million in 2017, and it is expected to grow at a CAGR of 6.7% during the period 2018 – 2024.The key factors driving the growth of urology guidewires market are; increasing prevalence of urological disorders and  government initiatives to provide better healthcare facilities. Moreover, technological advancement and new product launches, and growing number of surgeries across the globe have fuelled the demand for urology guidewires globally.

The years used for the assessment are as follows;

Historical year:2014, 2015, and 2016

Base year:2017

Forecast period:2018 – 2024

RESEARCH METHODOLOGY

The research and analysis is based on the data and information obtained from various primary and secondary sources. The data obtained is validated by interacting with the companies of the concerned domain. The steps involved in the research methodology are;

  • Obtaining historical data of the market based on news, articles, publications, government websites, annual reports, press releases, white papers, surveys, investor presentation of companies, and other secondary sources
  • Interacting with key opinion leaders of the market and developing data points based on interaction with them
  • Study of past trends in the market and their year on year Impact on the market size and share
  • Analyzing the collected data points
  • Bridging the data points to calculate the total global urology guidewire market and its various segments
  • Anticipating potential risks
  • Analyzing market forces such as drivers, restraints, and opportunities to assess new growth areas for the global urology guidewire market
  • Finalizing the overall size and share of the global urology guidewire market

OBJECTIVES:

  • To analyze market trends, opportunities, drivers, and restraints associated with the global urology guidewire market
  • To study market response with respect to the mergers and acquisitions in the industry
  • To profile key companies operating in the urology guidewire market and provide their competitive landscape

MARKET SCOPE

The research scope for global urology guidewire market is as follows:

By Product Type

  • Stainless Steel
  • Nitinol
  • Hybrid

By End-use

  • Ambulatory Surgical Centers
  • Hospitals
  • Specialty Clinics
  • Urological Surgery Centers

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Central & South America
  • Middle East and Africa

The global burden of urological diseases has increased in the recent years. Kidney diseases, and urological cancers are the most prevalent among the urological disorders. Chronic kidney diseases (CKD) are one of the most prevalent forms, affecting approximately 10% of the global population.Dietary and lifestyles changes have given rise to increasing incidences of kidney stones among men and women. Recurrent stone formation affects the quality of life, and may damage the kidney overtime. Globally, lifetime incidences of kidney stone are close to 15% for men and 10% in women. After a subject has formed a stone, the likelihood of recurrence is increased considerably. Increasing incidences of kidney related diseases are likely to propel the global guidewire market over the forecast period.

Moreover, the geriatric demographic of the world is growing at a steady rate. This rise in proportion of older population has led to increase in incidences of diseases. Urological disorders such as kidney stone, bladder cancer, kidney cancer, prostate cancer, and testicular cancer are one of the most common afflictions of the elderly. Due to financial security of the major proportion of this demographic, geriatric population can opt for treatments, surgical or otherwise, this has in turn propelled the market for urological guidewires for adults in the previous years.

The healthcare system in Europe gives equal access to quality healthcare at affordable costs. Countries in Europe aim to provide health coverage to all its citizens, this has resulted in good coverage for specialty diseases like urological disorders. Moreover, presence of established hospital network along with increasing number of ambulatory & specialty surgical centres is expected to give momentum to the market in this region.

Some of the key companies operating in the market include C. R. Bard, Inc., Teleflex Incorporated, TE Connectivity, LABORIE, OPTIMED, Heraeus Holding, Boston Scientific Corporation, COOK MEDICAL Inc., Olympus Corporation, Zhejiang Chuangxiang Medical Technology Co., Ltd, SSEM Mthembu Medical (Pty) Ltd., Hunan Reborn Medical Science and Technology Development Co., Ltd, Coloplast Ltd, Blue Neem Medical Devices Pvt Ltd, B. Braun Melsungen AG, and Cogentix Medical Inc. among others.Global urology guidewire market

TABLE OF CONTENTS

CHAPTER 1. Market Scope and Methodology

1.1. Research methodology

1.2. Research scope & assumptions

1.3. List of data sources

CHAPTER 2. Executive Summary

2.1. Urology Guidewire- Market Snapshot

CHAPTER 3. Industry Analysis

3.1. Market definition

3.2. Market segmentation

3.3. Key findings of the global urology guidewire market

3.4. Value chain analysis

3.5. Market opportunities & trends

3.5.1. Growing demand for nitinol based guidewires

3.5.2. Emergence of next-generation hybrid guidewires

3.6. Market driver analysis

3.6.1. Growing prevalence of urological disorders

3.6.2. Growing government initiatives to provide better healthcare facilities

3.6.3. Growing number of surgeries across the globe

CHAPTER 4. Competitive Outlook

4.1. Competitive analysis

4.1.1. Industry Analysis-Porters five forces of analysis

4.1.2. Company Share Analysis

4.2. Competitive factors

CHAPTER 5. Global Urology Guidewire Market Size and Forecast (2014 – 2024)

5.1. Global Urology Guidewire Market, By Product Type

5.1.1. Stainless Steel

5.1.2. Nitinol

5.1.3. Hybrid

5.2. Global Urology Guidewire Market, By End-use

5.2.1. Ambulatory Surgical Centers

5.2.2. Hospitals

5.2.3. Specialty Clinics

5.2.4. Urological Surgery Centers

CHAPTER 6. Global Urology Guidewire Market, By Geography

6.1. North America Urology Guidewire Market

6.1.1. North America Urology Guidewire Market, By Product Type (USD Million)

6.1.2. North America Urology Guidewire Market, By End-use (USD Million)

6.1.3. North America Urology Guidewire Market, By Country

   6.1.3.1. U.S.

   6.1.3.2. Canada

   6.1.3.3. Mexico

6.2. Europe Urology Guidewire Market

6.2.1. Europe Urology Guidewire Market, By Product Type (USD Million)

6.2.2. Europe Urology Guidewire Market, By End-use (USD Million)

6.2.3. Europe Urology Guidewire Market, By Country

   6.2.3.1. Germany

   6.2.3.2. France

   6.2.3.3. Russia

   6.2.3.4. Spain

   6.2.3.5. Italy

   6.2.3.6. U.K

   6.2.3.7. Rest of Europe

6.3. Asia-Pacific Urology Guidewire Market

6.3.1. Asia-Pacific Urology Guidewire Market, By Product Type (USD Million)

6.3.2. Asia-Pacific Urology Guidewire Market, By End-use (USD Million)

6.3.3. Asia-Pacific Urology Guidewire Market, By Country

   6.3.3.1. China

   6.3.3.2. Japan

   6.3.3.3. Australia

   6.3.3.4. India

   6.3.3.5. Rest of Asia-Pacific

6.4. Centeral and South America Urology Guidewire Market

6.4.1. Central and South America Urology Guidewire Market, By Product Type (USD Million)

6.4.2. Central and South America Urology Guidewire Market, By End-use (USD Million)

6.4.3. Central and South America Urology Guidewire Market, By Country

   6.4.3.1. Brazil

   6.4.3.2. Rest of Central and South America

6.5. Middle East and Africa Urology Guidewire Market

6.5.1. Middle East and Africa Urology Guidewire Market, By Product Type (USD Million)

6.5.2. Middle East and Africa Urology Guidewire Market, By End-use (USD Million)

6.5.3. Middle East and Africa Urology Guidewire Market, By Country

   6.5.3.1. South Africa

   6.5.3.2. Saudi Arabia

   6.5.3.3. Rest of Middle East and Africa

CHAPTER 7. Key Players and Strategic Developments

7.1. C. R. Bard, Inc.

7.1.1. Business Overview

7.1.2. Product and Service Offering

7.1.3. Financial Overview

7.1.4. Strategic Developments

7.2. Teleflex Incorporated

7.2.1. Business Overview

7.2.2. Product and Service Offering

7.2.3. Financial Overview

7.2.4. Strategic Developments

7.3. TE Connectivity

7.3.1. Business Overview

7.3.2. Product and Service Offering

7.3.3. Financial Overview

7.3.4. Strategic Developments

7.4. LABORIE

7.4.1. Business Overview

7.4.2. Product and Service Offering

7.4.3. Financial Overview

7.4.4. Strategic Developments

7.5. OPTIMED

7.5.1. Business Overview

7.5.2. Product and Service Offering

7.5.3. Financial Overview

7.5.4. Strategic Developments

7.6. Heraeus Holding

7.6.1. Business Overview

7.6.2. Product and Service Offering

7.6.3. Financial Overview

7.6.4. Strategic Developments

7.7. Boston Scientific Corporation

7.7.1. Business Overview

7.7.2. Product and Service Offering

7.7.3. Financial Overview

7.7.4. Strategic Developments

7.8. COOK MEDICAL Inc.

7.8.1. Business Overview

7.8.2. Product and Service Offering

7.8.3. Financial Overview

7.8.4. Strategic Developments

7.9. Olympus Corporation

7.9.1. Business Overview

7.9.2. Product and Service Offering

7.9.3. Financial Overview

7.9.4. Strategic Developments

7.10. Zhejiang Chuangxiang Medical Technology Co., Ltd

7.10.1. Business Overview

7.10.2. Product and Service Offering

7.10.3. Financial Overview

7.10.4. Strategic Developments

7.11. SSEM Mthembu Medical (Pty) Ltd.

7.11.1. Business Overview

7.11.2. Product and Service Offering

7.11.3. Financial Overview

7.11.4. Strategic Developments

7.12. Hunan Reborn Medical Science and Technology Development Co., Ltd

7.12.1. Business Overview

7.12.2. Product and Service Offering

7.12.3. Financial Overview

7.12.4. Strategic Developments

7.13. Coloplast Ltd

7.13.1. Business Overview

7.13.2. Product and Service Offering

7.13.3. Financial Overview

7.13.4. Strategic Developments

7.14. Blue Neem Medical Devices Pvt Ltd

7.14.1. Business Overview

7.14.2. Product and Service Offering

7.14.3. Financial Overview

7.14.4. Strategic Developments

7.15. B. Braun Melsungen AG

7.15.1. Business Overview

7.15.2. Product and Service Offering

7.15.3. Financial Overview

7.15.4. Strategic Developments

7.16. Cogentix Medical Inc.

7.16.1. Business Overview

7.16.2. Product and Service Offering

7.16.3. Financial Overview

7.16.4. Strategic Developments

7.17. Abbreviation

Global Urology Guidewire Market Outlook, Trend and Opportunity Analysis, Competitive Insights, Actionable Segmentation and Forecast 2024